Determination of BHR.
For invasive measurement of dynamic Resistance (R) and Compliance (C) twenty four hours after the last OVA aerosol challenge mice were anaesthetized with urethane, paralyzed using D-tubocurarine, tracheotomised and intubated with a 18G catheter, followed by mechanical ventilation with a Flexivent ® apparatus (SCIREQ, Montreal, Quebec, Canada). Respiratory frequency was set at 120 breaths/min with a tidal volume of 0.2 mL and a positive end-expiratory pressure of 2 mL H 2 O was applied. Increasing concentrations of metacholine (MCh) (0-600 µg/kg-1) were administered via the jugular vein. Dynamic resistance and compliance was recorded after a standardized inhalation manoeuvre given every 10 sec for 2 minutes [2] [3] [4] . Baseline resistance was restored before administering the subsequent doses of MCh.
Migration assay in vivo
To address migration of lung DCs, 80 µl of FITC-OVA (10 mg/ml), with or without ATP S was administered intratracheally 5 . 
Migration assay in vitro
DCs were generated from bone marrow cells cultured in GM-CSF. After 8 days of culture, cells were exposed overnight to ATP or to vehicle either in the presence or 
Real-time quantitative RT-PCR
Frozen cell pellets were homogenized, RNA isolated with RNeasy mini-prep columns (Qiagen, Hilden, Germany) and treated on-column with DNaseI, according to the manufacturer's protocol. RNA (100 ng) was reverse transcribed using SuperscriptII Cromoglycate), serum levels of total (normal range: < 100 kU/l) and allergen-specific (normal range: < 0.7 kU/l) Immunoglobulin E (IgE) in kilo units (kU/l), and the allergen (DP:Dermatophagoides pteronyssinus) and the dose (in allergen units, AU) used for segmental allergen challenge. * Patients had a lot of bacteria in the BAL, suggesting ongoing pulmonary infection, and were therefore excluded. 
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